Two-tier regenerative response in liver failure in humans

Area of Science:

• Hepatology
• Regenerative Medicine
• Gastroenterology

Background:

• Liver failure, both acute and chronic, presents a significant mortality risk.
• The liver's remarkable regenerative capacity is a key area of research.
• Understanding regeneration mechanisms is crucial for developing effective treatments.

Purpose of the Study:

• To evaluate the dual regenerative pathways in liver failure.
• To correlate liver regeneration markers with histological findings.
• To compare regeneration in acute liver failure (ALF), acute-on-chronic liver failure (ACLF), and decompensated cirrhosis (CHD).

Main Methods:

• Immunohistochemistry was used to analyze proliferating hepatocytes and activated hepatic progenitor cells (HPCs).
• Liver tissue samples from patients with ALF (25), ACLF (70), and CHD (70) were examined.
• Histological parameters were correlated with the expression of regenerative markers.

Main Results:

• Hepatocyte proliferation was highest in ALF, significantly exceeding that in ACLF and CHD.
• HPC proliferation was significantly higher in ACLF and CHD compared to ALF.
• ACLF demonstrated the highest HPC proliferation and differentiation, with more intermediate hepatocytes observed.
• Fibrosis/necrosis correlated with HPC activation in ACLF and CHD.

Conclusions:

• Hepatocyte proliferation serves as the primary regenerative response in ALF.
• HPC activation is a more prominent secondary response in ACLF.
• ACLF exhibits a greater potential for regeneration through HPC differentiation compared to CHD.